Cargando…

Angiogenesis Inhibitors as Anti-Cancer Therapy Following Renal Transplantation: A Case Report and Review of the Literature

Solid organ transplant recipients on long-term immunosuppressive medication are at increased risk of developing malignancy, and treatment of advanced cancers with angiogenesis inhibitors in this context has not been widely studied. We present a case of recurrent high-grade serous ovarian carcinoma t...

Descripción completa

Detalles Bibliográficos
Autores principales:	Kasherman, Lawrence, Doi, Jeffrey, Karakasis, Katherine, Schiff, Jeffrey, Kitchlu, Abhijat, Lheureux, Stephanie, Oza, Amit M.
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	MDPI 2021
Materias:	Case Report
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7924357/ https://www.ncbi.nlm.nih.gov/pubmed/33499164 http://dx.doi.org/10.3390/curroncol28010064

Ejemplares similares

Angiogenesis: A Pivotal Therapeutic Target in the Drug Development of Gynecologic Cancers
por: Kasherman, Lawrence, et al.
Publicado: (2022)

Can TP53 variant negative be high-grade serous ovarian carcinoma? A case series
por: Kasherman, Lawrence, et al.
Publicado: (2021)

Ovarian cancer treatment: The end of empiricism?
por: Lheureux, Stephanie, et al.
Publicado: (2015)

Ovarian Cancer and BRCA1/2 Testing: Opportunities to Improve Clinical Care and Disease Prevention
por: Karakasis, Katherine, et al.
Publicado: (2016)

Angiogenesis Inhibitors and Immunomodulation in Renal Cell Cancers: The Past, Present, and Future
por: Kasherman, Lawrence, et al.
Publicado: (2022)

Immune checkpoint inhibitor use in patients with end-stage kidney disease: an analysis of reported cases and literature review
por: Kitchlu, Abhijat, et al.
Publicado: (2021)

Chasing Immune Checkpoint Inhibitors in Ovarian Cancer: Novel Combinations and Biomarker Discovery
por: Colombo, Ilaria, et al.
Publicado: (2023)

Does treating with anti–PD-1 to improve glomerular health come without a cost?
por: Jhaveri, Kenar D., et al.
Publicado: (2022)

Overcoming Platinum and PARP-Inhibitor Resistance in Ovarian Cancer
por: McMullen, Michelle, et al.
Publicado: (2020)

Rucaparib: a novel PARP inhibitor for BRCA advanced ovarian cancer
por: Colombo, Ilaria, et al.
Publicado: (2018)

Ethical frameworks in clinical research processes during COVID-19: a scoping review
por: Kasherman, Lawrence, et al.
Publicado: (2021)

Measuring Quality of Life in Ovarian Cancer Clinical Trials—Can We Improve Objectivity and Cross Trial Comparisons?
por: Bhat, Gita, et al.
Publicado: (2020)

Manage wisely: poly (ADP-ribose) polymerase inhibitor (PARPi) treatment and adverse events
por: Madariaga, Ainhoa, et al.
Publicado: (2020)

DUETTE: a phase II randomized, multicenter study to investigate the efficacy and tolerability of a second maintenance treatment in patients with platinum-sensitive relapsed epithelial ovarian cancer, who have previously received poly(ADP-ribose) polymerase (PARP) inhibitor maintenance treatment
por: McMullen, Michelle, et al.
Publicado: (2020)

Immunotherapy in oncology and the kidneys: a clinical review of the evaluation and management of kidney immune-related adverse events
por: Rao Ullur, Avinash, et al.
Publicado: (2023)

Updates on systemic therapy for cervical cancer
por: Gopu, Paul, et al.
Publicado: (2021)

Tailoring Ovarian Cancer Treatment: Implications of BRCA1/2 Mutations
por: Madariaga, Ainhoa, et al.
Publicado: (2019)

A Systematic Review of Immune Checkpoint Inhibitor–Associated Glomerular Disease
por: Kitchlu, Abhijat, et al.
Publicado: (2020)

Outcomes of sustained low efficiency dialysis versus continuous renal replacement therapy in critically ill adults with acute kidney injury: a cohort study
por: Kitchlu, Abhijat, et al.
Publicado: (2015)

Pegylated Liposomal Doxorubicin and Kidney-Limited Thrombotic Microangiopathy in a Kidney Transplant Recipient: A Case Report
por: Rodriguez-Ramirez, Sonia, et al.
Publicado: (2022)

CKD After 225Ac-PSMA617 Therapy in Patients With Metastatic Prostate Cancer
por: Pelletier, Karyne, et al.
Publicado: (2020)

Amyloidoses in Onco-Nephrology Practice: A Multidisciplinary Case-Based Conference Report
por: Kitchlu, Abhijat, et al.
Publicado: (2023)

Chronic kidney disease, survival and graft-versus-host-disease-free/relapse-free survival in recipients of allogeneic hematopoietic stem cell transplant
por: Pelletier, Karyne, et al.
Publicado: (2022)

Perspectives From an Onconephrology Interest Group: Conference Report
por: Kitchlu, Abhijat, et al.
Publicado: (2020)

Light Chain Crystal Podocytopathy in a Patient With Systemic Indolent B-Cell Lymphoma
por: Kamar, Fareed, et al.
Publicado: (2019)

Heterogeneous alteration of the ERBB3–MYC axis associated with MEK inhibitor resistance in a KRAS-mutated low-grade serous ovarian cancer patient
por: Colombo, Ilaria, et al.
Publicado: (2019)

Acute kidney injury associated with immune checkpoint inhibitor therapy: incidence, risk factors and outcomes
por: Meraz-Muñoz, Alejandro, et al.
Publicado: (2020)

SGLT2 Inhibition in Patients With Type 2 Diabetes Mellitus Post-Nephrectomy: A Single-Center Case Series
por: Škrtić, Marko, et al.
Publicado: (2021)

Immune checkpoint inhibitors in ovarian cancer: where do we go from here?
por: Yoon, Won-Hee, et al.
Publicado: (2023)

Kidney and Cancer Outcomes with Standard Versus Alternative Chemotherapy Regimens for First-Line Treatment of Metastatic Urothelial Carcinoma
por: Côté, Gabrielle, et al.
Publicado: (2023)

Landscape of genomic alterations in high-grade serous ovarian cancer from exceptional long- and short-term survivors
por: Yang, S. Y. Cindy, et al.
Publicado: (2018)

Inhibition of nicotinamide dinucleotide salvage pathway counters acquired and intrinsic poly(ADP-ribose) polymerase inhibitor resistance in high-grade serous ovarian cancer
por: Sauriol, Alexandre, et al.
Publicado: (2023)

Pathological complete response after nivolumab therapy following angiogenesis inhibitors in a patient with metastatic renal cell carcinoma
por: Hagimoto, Hiroki, et al.
Publicado: (2020)

Optimizing the Care of Malignant Bowel Obstruction in Patients With Advanced Gynecologic Cancer
por: Lee, Yeh Chen, et al.
Publicado: (2019)

Disseminated intravascular coagulation complicating diagnosis of ROS1‐mutant non‐small cell lung cancer: A case report and literature review
por: Woodford, Rachel, et al.
Publicado: (2021)

What insights do patients and caregivers have on acute kidney injury and posthospitalisation care? A single-centre qualitative study from Toronto, Canada
por: Silver, Samuel A, et al.
Publicado: (2018)

Successful Renal Transplantation after Presumed Cyanide Toxicity Treated with Hydroxocobalamin and Review of the Literature
por: Hendrix, Ryan J., et al.
Publicado: (2018)

Multiple myeloma presenting with high-output heart failure and improving with anti-angiogenesis therapy: two case reports and a review of the literature
por: Robin, Jason, et al.
Publicado: (2008)

Adenovirus nephritis and obstructive uropathy in a renal transplant recipient: case report and literature review
por: Kolankiewicz, Luiz M., et al.
Publicado: (2010)

Immunomodulation in stable renal transplant recipients with concomitant tacrolimus and sirolimus therapy
por: Khanna, Ashwani, et al.
Publicado: (2002)

Cannot write session to /tmp/vufind_sessions/sess_m71mbnk3ilbpe7g2rccsa7mmd2